Long-term efficacy and safety of the Port Delivery System with ranibizumab in patients with neovascular age-related macular degeneration: Results from the Portal 5-year subgroup analysis

被引：0
|
作者：
Howard, James [1 ]
Cordeiro, Melina Cavichini [2 ]
Singh, Natasha [2 ]
Gune, Shamika [2 ]
机构：
[1] Retina Associates Utah, Salt Lake City, UT USA
[2] Genentech Inc, South San Francisco, CA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Efficacy and safety of intravitreal aflibercept in ranibizumab-refractory patients with neovascular age-related macular degeneration
    Sam Razavi
    Laurent Kodjikian
    Audrey Giocanti-Aurégan
    Ingrid Dufour
    Eric Souied
    BMC Ophthalmology, 21
  • [32] Population Pharmacokinetics of Ranibizumab Delivered via the Port Delivery System Implanted in the Eye in Patients with Neovascular Age-Related Macular Degeneration
    Kagedal, Matts
    Alskar, Oskar
    Petersson, Klas
    Hanze, Eva
    Maia, Mauricio
    Lu, Tong
    Vakhavkar, Shweta
    Quartino, Angelica
    Willis, Jeffrey R.
    Jin, Jin Y.
    Maass, Katie F.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (11): : 1210 - 1220
  • [33] End-of-Study Results for the Ladder Phase 2 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
    Khanani, Arshad M.
    Callanan, David
    Dreyer, Richard
    Chen, Sanford
    Howard, James G.
    Hopkins, J. Jill
    Lin, Chin-Yu
    Lorenz-Candlin, Meike
    Makadia, Sneha
    Patel, Shienal
    Tam, Tammy
    Gune, Shamika
    OPHTHALMOLOGY RETINA, 2021, 5 (08): : 775 - 787
  • [34] Ocular and systemic safety of bevacizumab and ranibizumab in patients with neovascular age-related macular degeneration
    Johnson, Davin
    Sharma, Sanjay
    CURRENT OPINION IN OPHTHALMOLOGY, 2013, 24 (03) : 205 - 212
  • [35] Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration
    Bekir Kü?ük
    Sibel Kaday?f??lar
    Bora Eldem
    International Journal of Ophthalmology, 2018, (04) : 645 - 649
  • [36] Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration
    Kucuk, Bekir
    Kadayifcilar, Sibel
    Eldem, Bora
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2018, 11 (04) : 645 - 649
  • [37] Short-term results of the switchback from aflibercept to ranibizumab in neovascular age-related macular degeneration
    Raphaelle, Despreaux
    Cohen, Salomon Y.
    Semoun, Oudy
    Zambrowski, Olivia
    Yung, Camille
    Oubraham, Hassiba
    Souied, Eric H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [38] Age-related macular degeneration: Long-term results of radiotherapy for subfoveal neovascular membranes
    Kobayashi, H
    Kobayashi, K
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2000, 130 (05) : 617 - 635
  • [39] Long-term efficacy and safety of ranibizumab administered pro re nata in Japanese patients with neovascular age-related macular degeneration in the EXTEND-I study
    Tano, Yasuo
    Ohji, Masahito
    ACTA OPHTHALMOLOGICA, 2011, 89 (03) : 208 - 217
  • [40] Phase 1 Clinical Study of the Port Delivery System with ranibizumab for continuous treatment of neovascular age-related macular degeneration
    Loewenstein, Anat
    Laganovska, Guna
    Bressler, Neil M.
    Vanags, Juris
    Alster, Yair
    De Juan, Eugene
    Stewart, Jay M.
    Kardatzke, David
    Singh, Natasha
    Erickson, Signe
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
12345